Condition: Interstitial Cystitis · Bladder Pain Syndrome · Sponsor: Vaneltix Pharma, Inc.
This is a Phase 2, prospective, randomized, double-blind, placebo-controlled, multi-center, single-dose, pharmacodynamic study designed to evaluate the efficacy and safety of the combination product (VNX001) versus placebo and its individual components (heparin sodium and lidocaine hydrochloride (HCl)) for the reduction of bladder pain in patients with interstitial cystitis (IC) / bladder pain syndrome (BPS), Who Have an Episode of Acute Bladder Pain of Moderate to Severe Intensity.
This description comes directly from the study's public registry record.
Vaneltix Pharma, Inc. · 732-354-3217 · info@vaneltix.com
Always discuss trial participation with your own doctor first.
| IC Study LLC | Escondido, California, United States | Suspended |
| University of California Los Angeles Center for Women's Pelvic Health | Los Angeles, California, United States | Completed |
| The Clark Center for Urogynecology | Newport Beach, California, United States | Recruiting |
| The Continence Center Medical Group, Inc dba Southern California Continence Center | Newport Beach, California, United States | Completed |
| University of California San Diego Medical Center | San Diego, California, United States | Recruiting |
| Prestige Medical Group | Tustin, California, United States | Recruiting |
| United Research Institute | Hialeah, Florida, United States | Recruiting |
| Florida Urology Partners | Tampa, Florida, United States | Recruiting |
| Georgia Urology | Cartersville, Georgia, United States | Recruiting |
| Southern Clinical Research Associates LLC | Metairie, Louisiana, United States | Recruiting |
| Bay State Clinical Trials | Watertown, Massachusetts, United States | Recruiting |
| Sheldon Freedman MD LTD | Las Vegas, Nevada, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05737121